SCHEMBL8554601

SCHEMBL8554601

OCCC=CCCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.58
GPR52 Q9Y2T5 16/20 0.53
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8554597 1.00 TDP1 (0.58) TDP1GPR52TSHR
SCHEMBL7762164 0.88 GPR52 (0.57) TDP1GPR52
SCHEMBL9715286 0.88 GPR52 (0.57) TDP1GPR52
SCHEMBL7762166 0.88 GPR52 (0.57) TDP1GPR52
SCHEMBL2243796 0.86 GPR52 (0.53) TDP1GPR52TSHR
SCHEMBL5974140 0.86 GPR52 (0.53) TDP1GPR52TSHR
SCHEMBL13078847 0.86 GPR52 (0.53) TDP1GPR52TSHR
SCHEMBL10375115 0.84 TDP1 (0.50) TDP1GPR52
SCHEMBL9734298 0.84 TDP1 (0.50) TDP1GPR52
SCHEMBL10375114 0.84 TDP1 (0.50) TDP1GPR52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0840725-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1998-05-13 EP disclosed
WO-1997002242-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-01-23 WO disclosed